Inventor
CHIVUKULA PADMANABH
US54 patents
⚠️ This page may combine multiple inventors who share the name “CHIVUKULA PADMANABH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARCTURUS THERAPEUTICS INC
47 patentsUS9593077B2Mar 14, 2017
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC88 citations99
US9567296B2Feb 14, 2017
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC77 citations99
US9670152B2Jun 6, 2017
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC52 citations98
US10526284B2Jan 7, 2020
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC16 citations94
US10487105B2Nov 26, 2019
Trinucleotide MRNA cap analogs
ARCTURUS THERAPEUTICS INC19 citations94
US9896413B2Feb 20, 2018
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC19 citations94
US9365610B2Jun 14, 2016
Asymmetric ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC30 citations94
US9951002B2Apr 24, 2018
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC12 citations93
US9850202B2Dec 26, 2017
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC15 citations93
US10383952B2Aug 20, 2019
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC13 citations92
US9580711B2Feb 28, 2017
Lipid particles with asymmetric cationic lipids for RNA delivery
ARCTURUS THERAPEUTICS INC20 citations92
USRE49233EOct 4, 2022
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC2 citations84
US10980895B2Apr 20, 2021
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC8 citations84
US10961188B2Mar 30, 2021
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC7 citations84
US10781169B2Sep 22, 2020
Method of synthesis of an ionizable cationic lipid
ARCTURUS THERAPEUTICS INC6 citations84
US10399937B2Sep 3, 2019
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC2 citations84
US10233148B2Mar 19, 2019
Aromatic ionizable cationic lipid
ARCTURUS THERAPEUTICS INC6 citations84
US10227302B2Mar 12, 2019
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC12 citations84
US9856475B2Jan 2, 2018
Formulations for treating amyloidosis
ARCTURUS THERAPEUTICS INC5 citations84
US11744887B2Sep 5, 2023
Coronavirus vaccine compositions and methods
ARCTURUS THERAPEUTICS INC4 citations82
US10369232B2Aug 6, 2019
Allele selective gene editing and uses thereof
ARCTURUS THERAPEUTICS INC14 citations81
US11015204B2May 25, 2021
Synthesis and structure of high potency RNA therapeutics
ARCTURUS THERAPEUTICS INC6 citations80
US10815463B2Oct 27, 2020
Messenger UNA molecules and uses thereof
ARCTURUS THERAPEUTICS INC6 citations73
US10556861B2Feb 11, 2020
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC1 citations73
US10421964B2Sep 24, 2019
UNA oligomers and compositions for treating amyloidosis
ARCTURUS THERAPEUTICS INC2 citations73
US9982259B2May 29, 2018
Transthyretin allele selective UNA oligomers for gene silencing
ARCTURUS THERAPEUTICS INC5 citations73
US9834510B2Dec 5, 2017
Aromatic ionizable cationic lipid
ARCTURUS THERAPEUTICS INC4 citations73
US11685906B2Jun 27, 2023
Compositions and methods for treating ornithine transcarbamylase deficiency
ARCTURUS THERAPEUTICS INC4 citations72
US12220455B2Feb 11, 2025
Coronavirus vaccine compositions and methods
ARCTURUS THERAPEUTICS INC1 citations71
US11759515B2Sep 19, 2023
Compositions and methods for inducing immune responses
ARCTURUS THERAPEUTICS INC1 citations70
USRE50681EDec 2, 2025
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC0 citations63
US12286395B2Apr 29, 2025
Method of synthesis of an ionizable cationic lipid
ARCTURUS THERAPEUTICS INC0 citations63
US12527881B2Jan 20, 2026
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC0 citations62
US12220485B2Feb 11, 2025
Method of making lipid-encapsulated RNA nanoparticles
ARCTURUS THERAPEUTICS INC0 citations62
US11737979B2Aug 29, 2023
Method of making lipid-encapsulated RNA nanoparticles
ARCTURUS THERAPEUTICS INC1 citations62
US12290567B2May 6, 2025
Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates
ARCTURUS THERAPEUTICS INC1 citations61
US12398379B2Aug 26, 2025
Compositions and methods for treating ornithine transcarbamylase deficiency
ARCTURUS THERAPEUTICS INC0 citations60
US12390524B2Aug 19, 2025
Compositions and methods for inducing immune responses
ARCTURUS THERAPEUTICS INC0 citations59
US11939363B2Mar 26, 2024
Translatable molecules and synthesis thereof
ARCTURUS THERAPEUTICS INC0 citations59
US11407800B2Aug 9, 2022
Translatable molecules and synthesis thereof
ARCTURUS THERAPEUTICS INC1 citations59
US12509698B2Dec 30, 2025
Synthesis and structure of high potency RNA therapeutics
ARCTURUS THERAPEUTICS INC0 citations58
US12070509B2Aug 27, 2024
Nucleic acids and methods of treatment for cystic fibrosis
ARCTURUS THERAPEUTICS INC1 citations57
US12351834B2Jul 8, 2025
Compositions and methods for the treatment of ornithine transcarbamylase deficiency
ARCTURUS THERAPEUTICS INC0 citations56
US11939600B2Mar 26, 2024
Compositions and methods for treating phenylketonuria
ARCTURUS THERAPEUTICS INC0 citations53
US10604758B2Mar 31, 2020
Therapeutic oligomers for treating amyloidosis
ARCTURUS THERAPEUTICS INC0 citations52
US10519447B2Dec 31, 2019
Therapeutic UNA oligomers and uses thereof
ARCTURUS THERAPEUTICS INC0 citations52
US9962449B2May 8, 2018
MultiLigand agent for drug delivery
ARCTURUS THERAPEUTICS INC0 citations52
C/O ARCTURUS THERAPEUTICS INC
1 patentUS GOV SEC ARMY
1 patentULTRAGENYX PHARMACEUTICAL INC
1 patentShowing the top 50 of 54 patents by PatentIndex Score.